Award reduced in Texas Vioxx case

Share this article:
A judge in a Texas lawsuit over Merck's Vioxx today reduced a $32 million jury award to $7.75 million, citing Texas' recently enacted caps on punitive damages, according to a story appearing on The Wall Street Journal's Web site.

The state jury in April found Merck liable for the death of Leonel Garza, a 71-year-old man who had a fatal heart attack within a month of taking the withdrawn painkiller. Merck was ordered to pay Garza's family $7 million in non-economic compensatory damages and $25 million in punitive damages.

But Judge Alex Gabert ordered the punitive damage reduced as required by state law. The law caps punitive damages at twice the amount of economic damages – lost pay—and up to $750,000 on top of non-economic damages. Because Garza was retired, the jury awarded no economic damages, so Merck was ordered to pay the most the family could receive under state law.
Share this article:

Email Newsletters

More in News

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.